EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Metabolic Reprogramming of Cancer Stem Cells: Targeting Lipid Flux and Mitochondrial Plasticity to Overcome Therapeutic Resistance

Daniel Ejim Uti iD, Esther Ugo Alum iD, Josephine E Egbung iD, Zuhair M Mohammedsaleh, Manpreet Kaur, Kranti Kiran Reddy Ealla iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.72275 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2026. Verfasst von Daniel Ejim Uti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue State, Niger…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Mitochondria, Drug Resistance, Neoplasm, Lipid Metabolism. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) are increasingly recognized as metabolically plastic subpopulations within malignant tissues that drive tumor initiation, metastatic dissemination, and relapse after therapy. Although traditional models of cancer metabolism have emphasized aerobic glycolysis, CSCs rarely exhibit a single, clearly defined bioenergetic phenotype. Rather, they dynamically remodel glucose utilization, oxidative phosphorylation, redox regulation, de novo fatty acid synthesis, lipid uptake, lipid sequestration, and fatty acid oxidation in response to hypoxic conditions, nutrient restriction, stromal interactions, and therapeutic perturbations. This review focuses on two interconnected aspects of metabolic flexibility: lipid flux and mitochondrial plasticity. We examine how de novo lipogenesis, CD36‐mediated fatty acid uptake, fatty acid‐binding protein trafficking, cholesterol biosynthesis, and lipid‐droplet turnover contribute to stemness, membrane remodeling, metastatic potential, and resistance to cytotoxic agents. We also examine how mitochondrial dynamics, including fusion, fission, mitophagy, and biogenesis, together with reactive oxygen species buffering and shifts in oxidative phosphorylation, facilitate CSC survival during chemotherapy, radiotherapy, targeted therapy, and immune‐mediated cytotoxicity. Particular emphasis is placed on the integration of fatty acid oxidation to respiratory metabolism, on the epigenetic consequences associated with the acetyl‐CoA availability, and the metabolic crosstalk linking CSCs to adipocytes, fibroblasts, mesenchymal cells, and immune cell populations in the tumor microenvironment. Finally, we evaluate therapeutic strategies involving inhibitors of fatty acid synthase (FASN), acetyl‐CoA carboxylase (ACC), stearoyl‐CoA desaturase‐1 (SCD1), carnitine palmitoyltransferase‐1 (CPT1), and OXPHOS. We also discuss combination therapies, nanotechnology‐based drug delivery, and emerging artificial intelligence (AI)‐guided approaches. Taken together, current evidence identifies the lipid–mitochondrial axis as a critical systems‐level driver of therapeutic resistance and a promising target for improving long‐term cancer control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsMitochondriaDrug Resistance, NeoplasmLipid MetabolismNeoplasmsHumansMetabolic ReprogrammingAnimalsMitochondrial DynamicsOxidative PhosphorylationAntineoplastic Agents

Stichwörter der Autor:innen

cancer stem cellslipid metabolismmetabolic plasticitymitochondrial dynamicstherapeutic resistance

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue State, Nigeria.
  • Department of Biochemistry, Research and Publications, Kampala International University, Kampala, Uganda.
  • Department of Biochemistry, Faculty of Science, Ebonyi State University, Abakaliki, Nigeria.
  • Department of Public Health Sciences, Faculty of Allied Health Sciences, University of Calabar, Calabar, Nigeria.
  • Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
  • School of Allied Health Sciences, CGC University, Mohali, Punjab, India.

ORCID-Profile: Daniel Ejim Uti, Esther Ugo Alum, Josephine E Egbung, Kranti Kiran Reddy Ealla

Zitieren

APA

Uti, D. E., Alum, E. U., Egbung, J. E., Mohammedsaleh, Z. M., Kaur, M., & Ealla, K. K. R. (2026). Metabolic Reprogramming of Cancer Stem Cells: Targeting Lipid Flux and Mitochondrial Plasticity to Overcome Therapeutic Resistance. Cancer Medicine. https://doi.org/10.1002/cam4.72275

Vancouver

Uti DE, Alum EU, Egbung JE, Mohammedsaleh ZM, Kaur M, Ealla KKR. Metabolic Reprogramming of Cancer Stem Cells: Targeting Lipid Flux and Mitochondrial Plasticity to Overcome Therapeutic Resistance. Cancer Medicine. 2026. doi:10.1002/cam4.72275

BibTeX
@article{Uti2026,
  author = {Uti, Daniel Ejim and Alum, Esther Ugo and Egbung, Josephine E and Mohammedsaleh, Zuhair M and Kaur, Manpreet and Ealla, Kranti Kiran Reddy},
  title = {Metabolic Reprogramming of Cancer Stem Cells: Targeting Lipid Flux and Mitochondrial Plasticity to Overcome Therapeutic Resistance},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72275}
}
Kostenlos starten →